Requirements Governing the Text of Patient Information Leaflet Trial Subject Information Sheet /Informed Consent Form
With effect as of June 1, 2022, the Guideline supersedes guideline KLH-22 version 4.
The guideline is issued on the basis and in accordance with the provisions of Section 51 (2) of Act No. 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (the Act on Pharmaceuticals), as amended, and Annex No. 2 to Decree No. 226/2008 Coll., on the Good Clinical Practice and More Detailed Conditions for Clinical trials on Pharmaceuticals as amended.
The Guideline is for recommendation.